Analystreport

Mirati Therapeutics Inc (NASDAQ: MRTX) was downgraded by analysts at Guggenheim from a "buy" rating to a "neutral" rating.

Mirati Therapeutics, Inc.  (MRTX) 
Last mirati therapeutics, inc. earnings: 2/25 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.mirati.com/node/5806